2004
DOI: 10.1016/j.jdermsci.2004.08.012
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
30
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 25 publications
5
30
0
Order By: Relevance
“…The lack of complete reversal with this maneuver is likely to be explained by the continued accumulation of tryptophan metabolites kynurenine, 3-hydroxykyrnurenine and 3-hydroxyanthranillic acid, which suppress T cell proliferation, although we did not formally test this (59). Supporting the relevance of this mechanism in vivo, up-regulated expression of IFN-␥, IDO, and increased tryptophan degradation have been found in psoriatic skin lesions (60) and in the intrinsic resistance of Fb to Toxoplasma gondii infection (61). We did not find any evidence for the role of PG in T cell-suppressive effects by dermal Fb or BM MSC.…”
Section: Discussionmentioning
confidence: 91%
“…The lack of complete reversal with this maneuver is likely to be explained by the continued accumulation of tryptophan metabolites kynurenine, 3-hydroxykyrnurenine and 3-hydroxyanthranillic acid, which suppress T cell proliferation, although we did not formally test this (59). Supporting the relevance of this mechanism in vivo, up-regulated expression of IFN-␥, IDO, and increased tryptophan degradation have been found in psoriatic skin lesions (60) and in the intrinsic resistance of Fb to Toxoplasma gondii infection (61). We did not find any evidence for the role of PG in T cell-suppressive effects by dermal Fb or BM MSC.…”
Section: Discussionmentioning
confidence: 91%
“…Of the two models, the NC model has been more widely used to compare the phenotype between human AD patients and the mice, to explore causative genes (Ito et al, 2004, Ogawa et al, 2005, Fallon et al, 2009, Jung et al, 2011 and genetic loci (Kohara et al, 2001), and for drug development (Yamamoto et al, 2007, Shah et al, 2010 and the therapy of human AD (Takeda and Gelfand, 2009). Therefore, the immunological, pathological and genetic characteristics have been extensively examined in detail.…”
Section: Details Of the Nc Modelmentioning
confidence: 99%
“…In mammals, tryptophan catabolism is well-known, but the amino acid and its degradation products are still under investigation because they are implicated in several nervous system pathologies (Fujigaki et al 1998;Wonodi and Schwarcz 2010;Campesan et al 2011) and in psoriasis (Ito et al 2004).…”
Section: Introductionmentioning
confidence: 99%